|Bid||39.17 x 84100|
|Ask||39.34 x 12400|
|Day's Range||39.02 - 40.30|
|52 Week Range||19.63 - 44.67|
|Beta (5Y Monthly)||0.41|
|PE Ratio (TTM)||80.93|
|Earnings Date||Aug 25, 2021|
|Forward Dividend & Yield||0.03 (0.06%)|
|Ex-Dividend Date||Sep 02, 2021|
|1y Target Est||33.92|
Subscribe to Yahoo Finance Plus to view Fair Value for CUV.AXLearn more
Greg Swenson, Brigg Macadam Founding Partner, joins Yahoo Finance to discuss the outlook on Bitcoin, upcoming bank earnings, and the state of the energy market.
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
Clinuvel Pharmaceuticals' (ASX:CUV) stock is up by a considerable 7.1% over the past week. Given the company's...